Navigation Links
Dr. M. Fatih Yanik joins Intellimedix
Date:6/12/2013

ATLANTA, June 12, 2013 /PRNewswire-iReach/ -- Dr. M. Fatih Yanik has recently joined the team at Intellimedix and will oversee the company's new technology development efforts. Dr. Yanik is an associate professor in the Electrical Engineering department of MIT and heads the school's High-Throughput Neurotechnology Group. In 2011, he was awarded the most prestigious NIH award, the NIH Director's Pioneer Award, and is the youngest recipient in the history of this award. Dr. Yanik is also the first person ever to receive all of the top NIH awards:  the NIH Director's New Innovator Award, the NIH EUREKA Award, the NIH Transformative Research Award, and the NIH Director's Pioneer Award.

"Fatih Yanik is a pioneer in the development of technologies for regenerative neurobiology and development of innovative drug discovery models and platforms. Additionally, Dr. Yanik and his research team have developed a novel and groundbreaking method of creating induced pluripotent stem cells (iPSCs) using RNA-based technology that holds great promise for personalized neurobiology. Fatih brings a treasure trove of talent to Intellimedix," says Dr. Jeffrey Skolnick, Chief Scientist at Intellimedix.

"Intellimedix has a very dedicated and world-class team who is truly passionate about finding cures for epilepsy and other neurological disorders. I am truly excited to join them in this endeavor as we set out to improve the quality of life for many people," says Dr. Yanik.

Dr. Yanik will play a major role in developing novel technologies and guiding the research at Intellimedix's Cambridge, MA based lab.

About IntelliMedix:

IntelliMedix was founded in early 2012 with the purpose of developing and applying novel technologies to accelerate the discovery of new therapies for neurological diseases and creating new approaches for personalized medicine. They employ cutting-edge technology that includes gene sequencing, in silico screening, optogenetics, synthetic biology, and high-throughput in vivo and in vitro models. The company's current focus is on developing new treatments for Dravet Syndrome and other types of intractable epilepsy. For more information, please visit http://www.intellimedix.com

Media Contact:

Joanna Morrison Intellimedix, 770.399.9930, jmorrison@intellimedix.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE IntelliMedix
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
2. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
3. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
4. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
5. David F. Harty Joins Systech International as Vice President
6. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
7. Ted Pacha Joins Pinnaclife as President of its Healthcare Distribution Division
8. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
9. Anthony Creed Joins DDSTUDIO As GM, Experience Design
10. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
11. American Society of Hematology joins European Hematology Association, Patient Groups in Issuing International Call to Action to Alleviate Drug Shortages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
Breaking Medicine News(10 mins):